First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 67 citations, 2014 year and closed oa status.